Appointments to bolster rapid scaling and execution of Pyxa™ spatial platform BOSTON, Feb. 10, 2026 /PRNewswire/ -- Stellaromics, a pioneer in high-resolution 3D spatial multi-omics, today announced ...

BOSTON, Oct. 14, 2025 /PRNewswire/ -- Stellaromics, a pioneer in 3D spatial biology, today announces the installation of the first Pyxa™ instrument at the University of Glasgow in the laboratory of Dr ...

BOSTON, Feb. 19, 2026 /PRNewswire/ -- Stellaromics today launched Pyxa™, the first commercially available platform to deliver multiplexed 3D spatial transcriptomics in intact tissue up to 100 ...

Biological systems are inherently three-dimensional—tissues form intricate layers, networks, and architectures where cells interact in ways that extend far beyond a flat plane. To capture the true ...

A startup that aims to provide 3D views into the inner workings of tissue, ultimately charting out deep cellular maps for a better understanding of organ function and disease, is getting a big boost.

Stellaromics, announced the completion of a Series B funding round in the amount of $80M. The round, led by Catalyst4 with participation from Stanford University Ventures, will support the development ...

Stellaromics, a start-up that uses multiomics technology to help researchers understand the spatial organization of cells and tissues, has raised $80 million in a series B financing. Catalyst4, a ...

Stellaromics, a leading provider of in situ spatial multi-omics technology, today announced that the company has raised $25 million in a Series A financing round. The Series A financing round included ...

BOSTON, Feb. 19, 2026 /PRNewswire/ -- Stellaromics today launched PyxaTM, the first commercially available platform to deliver multiplexed 3D spatial transcriptomics in intact tissue up to 100 ...